Premium
Small interfering RNA inhibits SARS‐CoV nucleocapsid gene expression in cultured cells and mouse muscles
Author(s) -
Zhao Ping,
Qin Zhao-Ling,
Ke Jin-Shan,
Lu Yang,
Liu Min,
Pan Wei,
Zhao Lan-Juan,
Cao Jie,
Qi Zhong-Tian
Publication year - 2005
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/j.febslet.2005.02.080
Subject(s) - small interfering rna , green fluorescent protein , gene expression , rna interference , microbiology and biotechnology , gene , biology , rna , virology , transfection , expression vector , coronavirus , gene silencing , messenger rna , covid-19 , medicine , recombinant dna , genetics , pathology , disease , infectious disease (medical specialty)
SARS‐CoV is a newly identified coronavirus that causes severe acute respiratory syndrome (SARS). Currently, there is no effective method available for prophylaxis and treatment of SARS‐CoV infections. In the present study, the influence of small interfering RNA (siRNA) on SARS‐CoV nucleocapsid (N) protein expression was detected in cultured cells and mouse muscles. Four siRNA expression cassettes driven by mouse U6 promoter targeting SARS‐CoV N gene were prepared, and their inhibitory effects on expression of N and enhanced green fluorescence protein (EGFP) fusion protein were observed. A candidate siRNA was proved to down‐regulate N and EGFP expression actively in a sequence‐specific manner. The expression vector of this siRNA was constructed and confirmed to reduce N and EGFP expression efficiently in both cultured cells and adult mouse muscles. Our findings suggest that the siRNA should provide the basis for prophylaxis and therapy of SARS‐CoV infection in human.